Macrogenics (MGNX) Total Current Liabilities (2012 - 2026)

Macrogenics (MGNX) has 15 years of Total Current Liabilities data on file, last reported at $95.9 million in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $95.9 million, up 73.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $95.9 million (up 73.05% YoY), and the FY2025 annual result was $43.1 million, down 22.36% from the prior year.
• Total Current Liabilities climbed to $95.9 million in Q1 2026 per MGNX's latest filing, from $43.1 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $95.9 million in Q1 2026 and troughed at $39.0 million in Q2 2025.
• A 5-year average of $54.2 million and a median of $51.3 million in 2023 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2026: Total Current Liabilities plunged 34.82% in 2022, then surged 73.05% in 2026.
• A 5-year view of Total Current Liabilities shows it stood at $48.6 million in 2022, then advanced by 15.42% to $56.1 million in 2023, then slipped by 1.03% to $55.5 million in 2024, then retreated by 22.36% to $43.1 million in 2025, then surged by 122.52% to $95.9 million in 2026.
• Business Quant data shows MGNX's Total Current Liabilities at $95.9 million in Q1 2026, $43.1 million in Q4 2025, and $44.5 million in Q3 2025.